STAT, June 19, 2017. Trump’s team is reportedly considering moves that would do little to address the problem — and would instead please the pharmaceutical industry.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Will a New FDA User Fee Discourage Medical Device Innovation?
Bloomberg June 12, 2017: The NCHR is warning that a new FDA user fee could make the de novo pathway more appealing by speeding up device reviews, but at the cost of safety. NCHR says this fast-track process often skips clinical trials and lacks solid scientific proof, putting patients at risk.
Read More »FDA Questions Effect of Abuse-Deterrent Opioids
June 13 2017: The NCHR cautions that opioids labeled as “abuse-deterrent” might not actually stop misuse and can still be abused, giving a false sense of safety. They urge the FDA to ensure that such labels accurately reflect the risks to protect patients from harm.
Read More »Misplaced Trust: Why FDA Approval Doesn’t Guarantee Drug Safety
Drugwatch May 8 2017: Many people think FDA-approved drugs are always safe, but that’s not true. This article explains how some medicines get approved too quickly, why drug companies have a big say in the process, and how patients can protect themselves by asking the right questions.
Read More »Amy Reed, MD, Morcellator Opponent, Dies of Uterine Cancer
Medscape, May 25 2017: Dr. Amy Reed, a mother of six and physician, died at 44 after her cancer spread during a routine surgery using a power morcellator. She and her husband led a campaign that prompted the FDA to warn against the device’s use, aiming to protect other women from similar harm.
Read More »